- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Clarification
In an article entitled “New PET crystal promises faster scans, better images” (SCAN 10/13/04), we identified a problem in the manufacture of a promising new PET crystal, called the BrilLanCe 380. We stated that “a few bugs in its manufacture still have to be worked out. The biggest is a tendency for the crystal to break.” The developer and manufacturer of this crystal, Saint Gobain Crystals, wishes to emphasize that once encapsulated in a finished detector, there is no problem or issue regarding “breakage” of the BrilLanCe crystal and that the finished detectors are mechanically robust.
In an article entitled "New PET crystal promises faster scans, better images" (SCAN 10/13/04), we identified a problem in the manufacture of a promising new PET crystal, called the BrilLanCe 380. We stated that "a few bugs in its manufacture still have to be worked out. The biggest is a tendency for the crystal to break." The developer and manufacturer of this crystal, Saint Gobain Crystals, wishes to emphasize that once encapsulated in a finished detector, there is no problem or issue regarding "breakage" of the BrilLanCe crystal and that the finished detectors are mechanically robust.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
